These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31190991)

  • 1. Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.
    Zhou X; Sun X; Zhao W; Fang X; Wang X
    Cancer Manag Res; 2019; 11():4243-4254. PubMed ID: 31190991
    [No Abstract]   [Full Text] [Related]  

  • 2. Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Huang JJ; Jiang WQ; Lin TY; Huang Y; Xu RH; Huang HQ; Li ZM
    Ann Oncol; 2011 Jan; 22(1):149-155. PubMed ID: 20595450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The derived neutrophil-lymphocyte ratio and the neutrophil-lymphocyte ratio are related to poor prognosis in Hodgkin lymphoma patients.
    Shen QQ; Gao J; Tao H; Wang ST; Wang FJ; Chen YY; Zhang X; Jia YQ
    Am J Blood Res; 2021; 11(1):100-110. PubMed ID: 33796397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.
    Li N; Zhang L; Song HL; Zhang J; Weng HW; Zou LQ
    Tumour Biol; 2017 May; 39(5):1010428317705503. PubMed ID: 28475009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma.
    Li N; Jiang M; Wu WC; Zou LQ
    Ann Hematol; 2022 Jul; 101(7):1545-1556. PubMed ID: 35635579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
    Oki Y; Yamamoto K; Kato H; Kuwatsuka Y; Taji H; Kagami Y; Morishima Y
    Eur J Haematol; 2008 Dec; 81(6):448-53. PubMed ID: 18691256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
    Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN
    Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
    Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
    J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma.
    Huang JJ; Li YJ; Xia Y; Wang Y; Wei WX; Zhu YJ; Lin TY; Huang HQ; Jiang WQ; Li ZM
    BMC Cancer; 2013 May; 13():222. PubMed ID: 23638998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
    Yao N; Hou Q; Zhang S; Xiao H; Liang Y; Xu X; Guo R; Li H; Lan S; Si H; Cao J
    Front Oncol; 2020; 10():877. PubMed ID: 32637354
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic significance of peripheral blood-derived neutrophil/lymphocyte ratio in patients with digestive cancer.
    Liu F; Luo H; Zhu Z; Zhu P; Huang J
    J Cell Physiol; 2019 Dec; 234(12):22775-22786. PubMed ID: 31140613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte/Monocyte Ratio is a Novel Predictor for Early Stage Extranodal Natural Killer/T-cell Lymphoma, Nasal Type.
    Wang QX; Li SH; Ji BY; Wang HY; Li YY; Feng LL; Chen K; Xia YF; Zhang YJ
    J Cancer; 2017; 8(6):1030-1037. PubMed ID: 28529616
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of prognostic impact of absolute lymphocyte count, absolute monocyte count, absolute lymphocyte count/absolute monocyte count prognostic score and ratio in patients with diffuse large B cell lymphoma.
    Markovic O; Popovic L; Marisavljevic D; Jovanovic D; Filipovic B; Stanisavljevic D; Matovina-Brko G; Hajder J; Matkovic T; Živkovic R; Stanisavljevic N; Todorović M; Petrovic D; Mihaljevic B
    Eur J Intern Med; 2014 Mar; 25(3):296-302. PubMed ID: 24565533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lower ALC/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified.
    Li Q; Gao S; Ma J; Liu S; Yue Y; Chen L; Li H; Wang X; Li D; Cao Z; Zhao Z; Wang X; Yu Y; Zhang Y; Wang Y
    Leuk Res; 2018 Oct; 73():5-11. PubMed ID: 30172956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A neutrophil/lymphocyte Ratio as a Significant Predictor for Patients with low-risk and early-stage Extranodal NK-T-cell Lymphoma.
    Wu W; Chen X; Li N; Luo Q; Zou L
    Indian J Hematol Blood Transfus; 2023 Apr; 39(2):228-236. PubMed ID: 37006977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma.
    Cox MC; Nofroni I; Ruco L; Amodeo R; Ferrari A; La Verde G; Cardelli P; Montefusco E; Conte E; Monarca B; Aloe-Spiriti MA
    Leuk Lymphoma; 2008 Sep; 49(9):1745-51. PubMed ID: 18798109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.
    De Angulo G; Yuen C; Palla SL; Anderson PM; Zweidler-McKay PA
    Cancer; 2008 Jan; 112(2):407-15. PubMed ID: 18058809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of absolute lymphocyte count/absolute monocyte count ratio at diagnosis in patients with multiple myeloma.
    Shin SJ; Roh J; Kim M; Jung MJ; Koh YW; Park CS; Yoon DH; Suh C; Park CJ; Chi HS; Huh J
    Korean J Pathol; 2013 Dec; 47(6):526-33. PubMed ID: 24421845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
    Watanabe R; Tomita N; Itabashi M; Ishibashi D; Yamamoto E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Hattori Y; Motohashi K; Takasaki H; Ohshima R; Hashimoto C; Yamazaki E; Fujimaki K; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
    Eur J Haematol; 2014 Mar; 92(3):204-10. PubMed ID: 24283206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma.
    Jang JE; Kim YR; Kim SJ; Cho H; Chung H; Lee JY; Park H; Kim Y; Cheong JW; Min YH; Kim JS
    Eur J Cancer; 2016 Apr; 57():127-35. PubMed ID: 26918738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.